Extracellular matrix deposition drives disease progression and reduces rapamycin response in lymphangioleiomyomatosis. - Clements D; Babaei-Jadidi R; Johnson J; Miller S; Shah N; Sand JMB; Leeming DJ; Borthwick LA; Fisher AJ; Dufour A; Johnson SR (The European respiratory journal, 2026)